Restech (Houston, TX, USA) announces Larylab® Technologies as our distribution partner for France. The Larylab team combines clinical excellence, practical experience in a clinical setting, and technical expertise with a history of commercial success in bringing global products to the French marketplace.
Maya Hallay-Dufour, Vocologist, Founder and Principal of Larylab commented “LPR is the subject of frequent discussions during scientific meetings in France. Several pathologies are correlated with it. ENTs, laryngologists, and phoniatricians in France are faced with the limits of available reflux examinations, they are depending on gastroenterologists’ diagnosis, where, in several cases they do not find an objective explanation for the symptoms which are nevertheless observed. Being aware of the need for a simple, fast and effective, objective test for LPR, Larylab met with Restech after studying their published clinical studies and having consulted a panel of French and European key opinion leaders in laryngology. French KOL practitioners all encouraged the introduction of Restech in France, as a long-awaited solution for the best care of their patients with an objective evaluation of LPR.”
Restech’s Dx-pH System for reflux diagnosis employs patented, proprietary sensor technology which measures aerosolized as well as liquid pH levels. It is the only pH monitor that can objectively measure refluxate in the upper airway, providing up to 48 hours of continuous assessment of the reflux exposure propagating patient symptoms. Using detailed data from the study report, clinicians are able to assess acid and alkaline levels and more precisely treat reflux disorders.
Larylab will provide an introduction to, expert training on, and generalized support of Restech’s unique pH sensor technology to the medical community in France.
Thomas Ball, VP of Clinical Affairs for Restech said, “As LPR and reflux discussions are increasing in France with each successive year, it is a great honor to have the opportunity to help physicians and patients with another diagnostic pathway. Larylab founder Maya Hallay-Dufour gained clinical knowledge of the Restech pH test in Luxembourg and Belgium, where her expertise was key to successfully expanding patient diagnosis into new practices.”
Debra Krahel, CEO of Restech states “Larylab is an ideal partner for our reflux diagnostic solutions. CEO and managing director, Maya Hallay-Dufour, comes with an impressive clinical background that is critical in supporting the education and implementation of this technology into clinical practice. We are excited to put our technology in the hands of premier physicians and clinicians in France.”
Restech, formed in 2003 is based in Houston, Texas. We believe there is a better way to manage reflux. When world-renowned physicians came to us looking for a pH sensor that works outside of the esophagus, our engineering team accepted the challenge. We quickly developed and launched the first real-time sensor that could function accurately in a non-liquid environment. Since then, we’ve been on a mission to find a new way to approach reflux, ensuring we understand the ins and outs of the disease state and the industry. Although it is highly complex, we are passionate about bringing simple, effective reflux solutions to patients and clinicians around the world. Our rapid growth reflects our dedication and passion–developing and seeking out new products across the reflux diagnostic and therapeutic continuum from surgical to home health.
Thomas Ball
VP of Clinical Affairs
+18586733700
tball@restech.com
www.restech.com
Larylab was formed in 2017 and based in Bonneuil-Matours, Nouvelle Aquitaine, France. It all started by creating a specialized training organization in laryngology and vocology that delivers high-quality training sessions all around the year in France. In 2020, Larylab developed a new branch to provide effective devices to support laryngology and vocology practitioners. Our values are to provide high quality devices with scientific evidence of efficacy and security that also responds to ethical care and ecological challenges. Larylab aims to contribute to the well-being and health of patients while reducing public health costs. For this, our range of medical devices is selected meticulously. We are in exclusive partnership with our manufacturers that meet our values, as for their innovative production, extended technical expertise and commitment, in particular in scientific evidence, in guarantee applied on their devices and in technical training support.
Larylab® Technologies
Maya Hallay-Dufour
+33 (0)6 48 89 29 76
maya.hallay@larylab.fr
www.larylab.fr
https://larylab.fr/technologies
Bree has been an integral part of Restech from the very beginning. She holds a Masters in Public Health from George Washington University, a BFA from The University of Kansas in Visual Communications, and is a National Board Certified Health & Wellness Coach. Her command of marketing, public health/health delivery systems, and human health behavior change gives her a unique perspective in developing effective marketing strategies for the company.
Physicians: Fill out the form below to complete your request to be added to the “Find-A-Doctor” map on restech.com
Thomas previously worked as a polysomnographic technologist in the Virginia Mason system, before moving into sales with Restech in 2007. After spending 9 years working with distributors across Europe, he was moved into an organizational role at the head office in Houston. In this capacity he works closely with sales and marketing to provide clinical support, manages clinical studies, and provides clinical perspectives on business development. In his spare time Thomas plays rugby for Houston Athletic Rugby Club.
Jeff has over 30 years of experience in the medical device industry and previously worked in sales at companies such as Encision Inc., Interventional Therapies, LLC, Boston Scientific, and United States Surgical Corporation. He has been working as the VP of Sales for Mederi Therapeutics since 2009 and now brings his extensive expertise to Restech. Jeff was part of the team that bridged the Mederi asset sale to Restech. His clinical knowledge of the Stretta and Secca technologies is invaluable. Jeff has three decades of physician relations experience that he brings to Restech as part of the leadership team.
Ray joined Restech in May 2018 as the Vice President for Sales. He has been in the medical device, and specifically in the GERD space for more than 18 years. Starting in sales at Sandhill Scientific pH diagnostics, he moved on to Curon Medical when Stretta and Secca were first introduced to the market. He then worked for Given Imaging when Curon closed operations. When Stretta was relaunced he joined Mederi as VP of Sales. Ray was instrumental in keeping Stretta alive and the customer based informed when Mederi ceased operation and assets were purchased by Restech. He is part of the leadership team directing all product sales for Restech. Ray graduated from Old Dominion University in Norfolk with a BS in Marketing and Business Administration.
Mark is a seasoned professional and Certified Public Accountant in Texas who brings a unique blend of creative vision and financial expertise to any leadership team. He worked as a Senior Executive for 15 years on a leadership team which grew a private equity backed cash logistics company performing at negative EBITDA on $100 million revenue into an international industry leader with superior profitability on revenue exceeding $1.5 billion. In addition, he spent 10 years as a Senior Manager at Price Waterhouse delivering results-oriented merger & acquisition, audit and strategic consulting services to middle market clientele including over 40 manufacturing, distribution, service, nonprofit and technology clients. Mark currently serves as a Chief Financial Officer and consulting CFO (seven years) providing in-house and outsourced CFO and transactional services to the middle market.
Larry is the CTO for Restech and holds a B.S. in Computer Science. He is a software architect specializing in remote patient monitoring, medical sensors, and clinical trial software. Larry holds a patent on massively distributed computing and has worked for a number of major software startup companies including Sybase, Oracle, and Teradata. Larry was also the co-founder of a startup to deliver advanced clinical pathways to patients using mobile devices and medical sensors. Larry is truly a pioneer and now a veteran in the deployment.
Jeff has a breadth of experience with over 25 years in engineering and executive positions within major fortune 100 healthcare companies. He also has proven success in startup medical technology companies. Jeff provides leadership in securing and managing Restech’s patent portfolio. He also built Restech’s compliance platform that established regulatory acceptance in 25+ countries worldwide. Jeff’s scientific support and in-depth understanding of the device industry set the foundation for current and future commercial innovations at Restech.
With nearly 30 years of working with physician thought leaders developing novel and emerging technologies, Leo has played a key role in the development and evolution of balloon angioplasty and stent technologies that revolutionized the therapy of cardiac disease. His experience was instrumental in the development of the patented platform technology which drives the Restech sensor. Leo provides a vision and passion for effecting change in the diagnosis and management of atypical reflux.
With over 20 years of executive experience in both the private and public sector, Debra brings a broad understanding of healthcare delivery system. With experience managing products aimed at wide scale disease and population management for 20 million subscribers, Debra has extensive experience in effectively and efficiently developing models of delivery that address specific health issues. Debra has also been involved in the legislative process and served as the elected President of the Independent Physician Association of California. Debra is dedicated to bringing tools to the healthcare market that improve and support the clinical process.